Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Aug 1;357(Pt 3):593–615. doi: 10.1042/0264-6021:3570593

Nitric oxide synthases: structure, function and inhibition.

W K Alderton 1, C E Cooper 1, R G Knowles 1
PMCID: PMC1221991  PMID: 11463332

Abstract

This review concentrates on advances in nitric oxide synthase (NOS) structure, function and inhibition made in the last seven years, during which time substantial advances have been made in our understanding of this enzyme family. There is now information on the enzyme structure at all levels from primary (amino acid sequence) to quaternary (dimerization, association with other proteins) structure. The crystal structures of the oxygenase domains of inducible NOS (iNOS) and vascular endothelial NOS (eNOS) allow us to interpret other information in the context of this important part of the enzyme, with its binding sites for iron protoporphyrin IX (haem), biopterin, L-arginine, and the many inhibitors which interact with them. The exact nature of the NOS reaction, its mechanism and its products continue to be sources of controversy. The role of the biopterin cofactor is now becoming clearer, with emerging data implicating one-electron redox cycling as well as the multiple allosteric effects on enzyme activity. Regulation of the NOSs has been described at all levels from gene transcription to covalent modification and allosteric regulation of the enzyme itself. A wide range of NOS inhibitors have been discussed, interacting with the enzyme in diverse ways in terms of site and mechanism of inhibition, time-dependence and selectivity for individual isoforms, although there are many pitfalls and misunderstandings of these aspects. Highly selective inhibitors of iNOS versus eNOS and neuronal NOS have been identified and some of these have potential in the treatment of a range of inflammatory and other conditions in which iNOS has been implicated.

Full Text

The Full Text of this article is available as a PDF (460.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Soud H. M., Gachhui R., Raushel F. M., Stuehr D. J. The ferrous-dioxy complex of neuronal nitric oxide synthase. Divergent effects of L-arginine and tetrahydrobiopterin on its stability. J Biol Chem. 1997 Jul 11;272(28):17349–17353. doi: 10.1074/jbc.272.28.17349. [DOI] [PubMed] [Google Scholar]
  2. Abu-Soud H. M., Rousseau D. L., Stuehr D. J. Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension. J Biol Chem. 1996 Dec 20;271(51):32515–32518. doi: 10.1074/jbc.271.51.32515. [DOI] [PubMed] [Google Scholar]
  3. Abu-Soud H. M., Wang J., Rousseau D. L., Fukuto J. M., Ignarro L. J., Stuehr D. J. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem. 1995 Sep 29;270(39):22997–23006. doi: 10.1074/jbc.270.39.22997. [DOI] [PubMed] [Google Scholar]
  4. Abu-Soud H. M., Yoho L. L., Stuehr D. J. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. Activation of intra- and interdomain electron transfer. J Biol Chem. 1994 Dec 23;269(51):32047–32050. [PubMed] [Google Scholar]
  5. Adak S., Crooks C., Wang Q., Crane B. R., Tainer J. A., Getzoff E. D., Stuehr D. J. Tryptophan 409 controls the activity of neuronal nitric-oxide synthase by regulating nitric oxide feedback inhibition. J Biol Chem. 1999 Sep 17;274(38):26907–26911. doi: 10.1074/jbc.274.38.26907. [DOI] [PubMed] [Google Scholar]
  6. Adak S., Ghosh S., Abu-Soud H. M., Stuehr D. J. Role of reductase domain cluster 1 acidic residues in neuronal nitric-oxide synthase. Characterization of the FMN-FREE enzyme. J Biol Chem. 1999 Aug 6;274(32):22313–22320. doi: 10.1074/jbc.274.32.22313. [DOI] [PubMed] [Google Scholar]
  7. Adams D. R., Brochwicz-Lewinski M., Butler A. R. Nitric oxide: physiological roles, biosynthesis and medical uses. Fortschr Chem Org Naturst. 1999;76:1–211. doi: 10.1007/978-3-7091-6351-1_1. [DOI] [PubMed] [Google Scholar]
  8. Alderton W. K., Boyhan A., Lowe P. N. Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay. Biochem J. 1998 May 15;332(Pt 1):195–201. doi: 10.1042/bj3320195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Amin A. R., Di Cesare P. E., Vyas P., Attur M., Tzeng E., Billiar T. R., Stuchin S. A., Abramson S. B. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med. 1995 Dec 1;182(6):2097–2102. doi: 10.1084/jem.182.6.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Babu B. R., Griffith O. W. Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol. 1998 Aug;2(4):491–500. doi: 10.1016/s1367-5931(98)80125-7. [DOI] [PubMed] [Google Scholar]
  11. Babu B. R., Griffith O. W. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J Biol Chem. 1998 Apr 10;273(15):8882–8889. doi: 10.1074/jbc.273.15.8882. [DOI] [PubMed] [Google Scholar]
  12. Baek K. J., Thiel B. A., Lucas S., Stuehr D. J. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem. 1993 Oct 5;268(28):21120–21129. [PubMed] [Google Scholar]
  13. Bates T. E., Loesch A., Burnstock G., Clark J. B. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem Biophys Res Commun. 1995 Aug 24;213(3):896–900. doi: 10.1006/bbrc.1995.2213. [DOI] [PubMed] [Google Scholar]
  14. Bates T. E., Loesch A., Burnstock G., Clark J. B. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun. 1996 Jan 5;218(1):40–44. doi: 10.1006/bbrc.1996.0008. [DOI] [PubMed] [Google Scholar]
  15. Bec N., Gorren A. C., Voelker C., Mayer B., Lange R. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. Evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin. J Biol Chem. 1998 May 29;273(22):13502–13508. doi: 10.1074/jbc.273.22.13502. [DOI] [PubMed] [Google Scholar]
  16. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bender A. T., Silverstein A. M., Demady D. R., Kanelakis K. C., Noguchi S., Pratt W. B., Osawa Y. Neuronal nitric-oxide synthase is regulated by the Hsp90-based chaperone system in vivo. J Biol Chem. 1999 Jan 15;274(3):1472–1478. doi: 10.1074/jbc.274.3.1472. [DOI] [PubMed] [Google Scholar]
  18. Biegański T., Kusche J., Lorenz W., Hesterberg R., Stahlknecht C. D., Feussner K. D. Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta. 1983 Mar 31;756(2):196–203. doi: 10.1016/0304-4165(83)90092-2. [DOI] [PubMed] [Google Scholar]
  19. Boggs S., Huang L., Stuehr D. J. Formation and reactions of the heme-dioxygen intermediate in the first and second steps of nitric oxide synthesis as studied by stopped-flow spectroscopy under single-turnover conditions. Biochemistry. 2000 Mar 7;39(9):2332–2339. doi: 10.1021/bi9920228. [DOI] [PubMed] [Google Scholar]
  20. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990 Jan;87(2):682–685. doi: 10.1073/pnas.87.2.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Brenman J. E., Chao D. S., Gee S. H., McGee A. W., Craven S. E., Santillano D. R., Wu Z., Huang F., Xia H., Peters M. F. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell. 1996 Mar 8;84(5):757–767. doi: 10.1016/s0092-8674(00)81053-3. [DOI] [PubMed] [Google Scholar]
  22. Brenman J. E., Xia H., Chao D. S., Black S. M., Bredt D. S. Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci. 1997;19(3):224–231. doi: 10.1159/000111211. [DOI] [PubMed] [Google Scholar]
  23. Bryk R., Wolff D. J. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine. Biochemistry. 1998 Apr 7;37(14):4844–4852. doi: 10.1021/bi972065t. [DOI] [PubMed] [Google Scholar]
  24. Bryk R., Wolff D. J. Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors. Pharmacol Ther. 1999 Nov;84(2):157–178. doi: 10.1016/s0163-7258(99)00030-3. [DOI] [PubMed] [Google Scholar]
  25. Bömmel H. M., Reif A., Fröhlich L. G., Frey A., Hofmann H., Marecak D. M., Groehn V., Kotsonis P., La M., Köster S. Anti-pterins as tools to characterize the function of tetrahydrobiopterin in NO synthase. J Biol Chem. 1998 Dec 11;273(50):33142–33149. doi: 10.1074/jbc.273.50.33142. [DOI] [PubMed] [Google Scholar]
  26. Chabrier P. E., Demerlé-Pallardy C., Auguet M. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci. 1999 Jul;55(8-9):1029–1035. doi: 10.1007/s000180050353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Charles I. G., Palmer R. M., Hickery M. S., Bayliss M. T., Chubb A. P., Hall V. S., Moss D. W., Moncada S. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11419–11423. doi: 10.1073/pnas.90.23.11419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Chen P. F., Tsai A. L., Berka V., Wu K. K. Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem. 1996 Jun 14;271(24):14631–14635. [PubMed] [Google Scholar]
  29. Chen P. F., Tsai A. L., Berka V., Wu K. K. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers. J Biol Chem. 1997 Mar 7;272(10):6114–6118. doi: 10.1074/jbc.272.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Chen P. F., Tsai A. L., Wu K. K. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun. 1995 Oct 24;215(3):1119–1129. doi: 10.1006/bbrc.1995.2579. [DOI] [PubMed] [Google Scholar]
  31. Christopherson K. S., Hillier B. J., Lim W. A., Bredt D. S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem. 1999 Sep 24;274(39):27467–27473. doi: 10.1074/jbc.274.39.27467. [DOI] [PubMed] [Google Scholar]
  32. Clague M. J., Wishnok J. S., Marletta M. A. Formation of N delta-cyanoornithine from NG-hydroxy-L-arginine and hydrogen peroxide by neuronal nitric oxide synthase: implications for mechanism. Biochemistry. 1997 Nov 25;36(47):14465–14473. doi: 10.1021/bi971024u. [DOI] [PubMed] [Google Scholar]
  33. Cooper C. E. Nitric oxide and iron proteins. Biochim Biophys Acta. 1999 May 5;1411(2-3):290–309. doi: 10.1016/s0005-2728(99)00021-3. [DOI] [PubMed] [Google Scholar]
  34. Corson M. A., James N. L., Latta S. E., Nerem R. M., Berk B. C., Harrison D. G. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res. 1996 Nov;79(5):984–991. doi: 10.1161/01.res.79.5.984. [DOI] [PubMed] [Google Scholar]
  35. Crane B. R., Arvai A. S., Gachhui R., Wu C., Ghosh D. K., Getzoff E. D., Stuehr D. J., Tainer J. A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science. 1997 Oct 17;278(5337):425–431. doi: 10.1126/science.278.5337.425. [DOI] [PubMed] [Google Scholar]
  36. Crane B. R., Arvai A. S., Ghosh D. K., Wu C., Getzoff E. D., Stuehr D. J., Tainer J. A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science. 1998 Mar 27;279(5359):2121–2126. doi: 10.1126/science.279.5359.2121. [DOI] [PubMed] [Google Scholar]
  37. Crane B. R., Arvai A. S., Ghosh S., Getzoff E. D., Stuehr D. J., Tainer J. A. Structures of the N(omega)-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins. Biochemistry. 2000 Apr 25;39(16):4608–4621. doi: 10.1021/bi992409a. [DOI] [PubMed] [Google Scholar]
  38. Crane B. R., Rosenfeld R. J., Arvai A. S., Ghosh D. K., Ghosh S., Tainer J. A., Stuehr D. J., Getzoff E. D. N-terminal domain swapping and metal ion binding in nitric oxide synthase dimerization. EMBO J. 1999 Nov 15;18(22):6271–6281. doi: 10.1093/emboj/18.22.6271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Cubberley R. R., Alderton W. K., Boyhan A., Charles I. G., Lowe P. N., Old R. W. Cysteine-200 of human inducible nitric oxide synthase is essential for dimerization of haem domains and for binding of haem, nitroarginine and tetrahydrobiopterin. Biochem J. 1997 Apr 1;323(Pt 1):141–146. doi: 10.1042/bj3230141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Cutruzzolà F. Bacterial nitric oxide synthesis. Biochim Biophys Acta. 1999 May 5;1411(2-3):231–249. doi: 10.1016/s0005-2728(99)00017-1. [DOI] [PubMed] [Google Scholar]
  41. Daff S., Sagami I., Shimizu T. The 42-amino acid insert in the FMN domain of neuronal nitric-oxide synthase exerts control over Ca(2+)/calmodulin-dependent electron transfer. J Biol Chem. 1999 Oct 22;274(43):30589–30595. doi: 10.1074/jbc.274.43.30589. [DOI] [PubMed] [Google Scholar]
  42. Dawson J., Knowles R. G. A microtiter-plate assay of human NOS isoforms. Methods Mol Biol. 1998;100:237–242. doi: 10.1385/1-59259-749-1:237. [DOI] [PubMed] [Google Scholar]
  43. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999 Jun 10;399(6736):601–605. doi: 10.1038/21224. [DOI] [PubMed] [Google Scholar]
  44. Eissa N. T., Strauss A. J., Haggerty C. M., Choo E. K., Chu S. C., Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J Biol Chem. 1996 Oct 25;271(43):27184–27187. doi: 10.1074/jbc.271.43.27184. [DOI] [PubMed] [Google Scholar]
  45. Eissa N. T., Yuan J. W., Haggerty C. M., Choo E. K., Palmer C. D., Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7625–7630. doi: 10.1073/pnas.95.13.7625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Eliasson M. J., Blackshaw S., Schell M. J., Snyder S. H. Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3396–3401. doi: 10.1073/pnas.94.7.3396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fan J. S., Zhang Q., Li M., Tochio H., Yamazaki T., Shimizu M., Zhang M. Protein inhibitor of neuronal nitric-oxide synthase, PIN, binds to a 17-amino acid residue fragment of the enzyme. J Biol Chem. 1998 Dec 11;273(50):33472–33481. doi: 10.1074/jbc.273.50.33472. [DOI] [PubMed] [Google Scholar]
  48. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch Pharmacol. 1998 Jul;358(1):113–122. doi: 10.1007/pl00005231. [DOI] [PubMed] [Google Scholar]
  49. Feron O., Belhassen L., Kobzik L., Smith T. W., Kelly R. A., Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996 Sep 13;271(37):22810–22814. doi: 10.1074/jbc.271.37.22810. [DOI] [PubMed] [Google Scholar]
  50. Fischmann T. O., Hruza A., Niu X. D., Fossetta J. D., Lunn C. A., Dolphin E., Prongay A. J., Reichert P., Lundell D. J., Narula S. K. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999 Mar;6(3):233–242. doi: 10.1038/6675. [DOI] [PubMed] [Google Scholar]
  51. Fisslthaler B., Dimmeler S., Hermann C., Busse R., Fleming I. Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand. 2000 Jan;168(1):81–88. doi: 10.1046/j.1365-201x.2000.00627.x. [DOI] [PubMed] [Google Scholar]
  52. Fujisawa H., Ogura T., Kurashima Y., Yokoyama T., Yamashita J., Esumi H. Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines. J Neurochem. 1994 Jul;63(1):140–145. doi: 10.1046/j.1471-4159.1994.63010140.x. [DOI] [PubMed] [Google Scholar]
  53. Fulton D., Gratton J. P., McCabe T. J., Fontana J., Fujio Y., Walsh K., Franke T. F., Papapetropoulos A., Sessa W. C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999 Jun 10;399(6736):597–601. doi: 10.1038/21218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Furfine E. S., Harmon M. F., Paith J. E., Knowles R. G., Salter M., Kiff R. J., Duffy C., Hazelwood R., Oplinger J. A., Garvey E. P. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem. 1994 Oct 28;269(43):26677–26683. [PubMed] [Google Scholar]
  55. Förstermann U., Boissel J. P., Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998 Jul;12(10):773–790. [PubMed] [Google Scholar]
  56. Gachhui R., Abu-Soud H. M., Ghosha D. K., Presta A., Blazing M. A., Mayer B., George S. E., Stuehr D. J. Neuronal nitric-oxide synthase interaction with calmodulin-troponin C chimeras. J Biol Chem. 1998 Mar 6;273(10):5451–5454. doi: 10.1074/jbc.273.10.5451. [DOI] [PubMed] [Google Scholar]
  57. Gachhui R., Ghosh D. K., Wu C., Parkinson J., Crane B. R., Stuehr D. J. Mutagenesis of acidic residues in the oxygenase domain of inducible nitric-oxide synthase identifies a glutamate involved in arginine binding. Biochemistry. 1997 Apr 29;36(17):5097–5103. doi: 10.1021/bi970331x. [DOI] [PubMed] [Google Scholar]
  58. Gachhui R., Presta A., Bentley D. F., Abu-Soud H. M., McArthur R., Brudvig G., Ghosh D. K., Stuehr D. J. Characterization of the reductase domain of rat neuronal nitric oxide synthase generated in the methylotrophic yeast Pichia pastoris. Calmodulin response is complete within the reductase domain itself. J Biol Chem. 1996 Aug 23;271(34):20594–20602. doi: 10.1074/jbc.271.34.20594. [DOI] [PubMed] [Google Scholar]
  59. García-Cardeña G., Fan R., Shah V., Sorrentino R., Cirino G., Papapetropoulos A., Sessa W. C. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998 Apr 23;392(6678):821–824. doi: 10.1038/33934. [DOI] [PubMed] [Google Scholar]
  60. García-Cardeña G., Martasek P., Masters B. S., Skidd P. M., Couet J., Li S., Lisanti M. P., Sessa W. C. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem. 1997 Oct 10;272(41):25437–25440. doi: 10.1074/jbc.272.41.25437. [DOI] [PubMed] [Google Scholar]
  61. García-Cardeña G., Oh P., Liu J., Schnitzer J. E., Sessa W. C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6448–6453. doi: 10.1073/pnas.93.13.6448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Garvey E. P., Oplinger J. A., Furfine E. S., Kiff R. J., Laszlo F., Whittle B. J., Knowles R. G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997 Feb 21;272(8):4959–4963. doi: 10.1074/jbc.272.8.4959. [DOI] [PubMed] [Google Scholar]
  63. Garvey E. P., Oplinger J. A., Tanoury G. J., Sherman P. A., Fowler M., Marshall S., Harmon M. F., Paith J. E., Furfine E. S. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem. 1994 Oct 28;269(43):26669–26676. [PubMed] [Google Scholar]
  64. Geller D. A., Billiar T. R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 1998 Mar;17(1):7–23. doi: 10.1023/a:1005940202801. [DOI] [PubMed] [Google Scholar]
  65. Geller D. A., Lowenstein C. J., Shapiro R. A., Nussler A. K., Di Silvio M., Wang S. C., Nakayama D. K., Simmons R. L., Snyder S. H., Billiar T. R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3491–3495. doi: 10.1073/pnas.90.8.3491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ghafourifar P., Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 1997 Dec 1;418(3):291–296. doi: 10.1016/s0014-5793(97)01397-5. [DOI] [PubMed] [Google Scholar]
  67. Ghosh D. K., Abu-Soud H. M., Stuehr D. J. Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthase. Biochemistry. 1995 Sep 12;34(36):11316–11320. doi: 10.1021/bi00036a003. [DOI] [PubMed] [Google Scholar]
  68. Ghosh D. K., Stuehr D. J. Macrophage NO synthase: characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction. Biochemistry. 1995 Jan 24;34(3):801–807. doi: 10.1021/bi00003a013. [DOI] [PubMed] [Google Scholar]
  69. Ghosh S., Gachhui R., Crooks C., Wu C., Lisanti M. P., Stuehr D. J. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem. 1998 Aug 28;273(35):22267–22271. doi: 10.1074/jbc.273.35.22267. [DOI] [PubMed] [Google Scholar]
  70. Ghosh S., Wolan D., Adak S., Crane B. R., Kwon N. S., Tainer J. A., Getzoff E. D., Stuehr D. J. Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase. J Biol Chem. 1999 Aug 20;274(34):24100–24112. doi: 10.1074/jbc.274.34.24100. [DOI] [PubMed] [Google Scholar]
  71. Giardino I., Fard A. K., Hatchell D. L., Brownlee M. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes. 1998 Jul;47(7):1114–1120. doi: 10.2337/diabetes.47.7.1114. [DOI] [PubMed] [Google Scholar]
  72. Giovanelli J., Campos K. L., Kaufman S. Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7091–7095. doi: 10.1073/pnas.88.16.7091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J. 1998 Jun 15;332(Pt 3):673–679. doi: 10.1042/bj3320673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Giulivi C., Poderoso J. J., Boveris A. Production of nitric oxide by mitochondria. J Biol Chem. 1998 May 1;273(18):11038–11043. doi: 10.1074/jbc.273.18.11038. [DOI] [PubMed] [Google Scholar]
  75. Grant S. K., Green B. G., Stiffey-Wilusz J., Durette P. L., Shah S. K., Kozarich J. W. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Biochemistry. 1998 Mar 24;37(12):4174–4180. doi: 10.1021/bi972481d. [DOI] [PubMed] [Google Scholar]
  76. Griffith O. W., Stuehr D. J. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol. 1995;57:707–736. doi: 10.1146/annurev.ph.57.030195.003423. [DOI] [PubMed] [Google Scholar]
  77. Hagen T. J., Bergmanis A. A., Kramer S. W., Fok K. F., Schmelzer A. E., Pitzele B. S., Swenton L., Jerome G. M., Kornmeier C. M., Moore W. M. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase. J Med Chem. 1998 Sep 10;41(19):3675–3683. doi: 10.1021/jm970840x. [DOI] [PubMed] [Google Scholar]
  78. Hall A. V., Antoniou H., Wang Y., Cheung A. H., Arbus A. M., Olson S. L., Lu W. C., Kau C. L., Marsden P. A. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem. 1994 Dec 30;269(52):33082–33090. [PubMed] [Google Scholar]
  79. Handy R. L., Moore P. K. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol. 1998 Mar;123(6):1119–1126. doi: 10.1038/sj.bjp.0701735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Hansen D. W., Jr, Peterson K. B., Trivedi M., Kramer S. W., Webber R. K., Tjoeng F. S., Moore W. M., Jerome G. M., Kornmeier C. M., Manning P. T. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS). J Med Chem. 1998 Apr 23;41(9):1361–1366. doi: 10.1021/jm9704715. [DOI] [PubMed] [Google Scholar]
  81. Hansen J., Jacobsen T. N., Victor R. G. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension. 1994 Oct;24(4):439–444. doi: 10.1161/01.hyp.24.4.439. [DOI] [PubMed] [Google Scholar]
  82. Hayashi Y., Nishio M., Naito Y., Yokokura H., Nimura Y., Hidaka H., Watanabe Y. Regulation of neuronal nitric-oxide synthase by calmodulin kinases. J Biol Chem. 1999 Jul 16;274(29):20597–20602. doi: 10.1074/jbc.274.29.20597. [DOI] [PubMed] [Google Scholar]
  83. Haynes W. G., Noon J. P., Walker B. R., Webb D. J. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993 Dec;11(12):1375–1380. doi: 10.1097/00004872-199312000-00009. [DOI] [PubMed] [Google Scholar]
  84. Hecker M., Walsh D. T., Vane J. R. Characterization of a microsomal calcium-dependent nitric oxide synthase in activated J774.2 monocyte/macrophages. J Cardiovasc Pharmacol. 1992;20 (Suppl 12):S139–S141. doi: 10.1097/00005344-199204002-00039. [DOI] [PubMed] [Google Scholar]
  85. Heinzel B., John M., Klatt P., Böhme E., Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 1992 Feb 1;281(Pt 3):627–630. doi: 10.1042/bj2810627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Hemmens B., Goessler W., Schmidt K., Mayer B. Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. J Biol Chem. 2000 Nov 17;275(46):35786–35791. doi: 10.1074/jbc.M005976200. [DOI] [PubMed] [Google Scholar]
  87. Hemmens B., Woschitz S., Pitters E., Klösch B., Völker C., Schmidt K., Mayer B. The protein inhibitor of neuronal nitric oxide synthase (PIN): characterization of its action on pure nitric oxide synthases. FEBS Lett. 1998 Jul 3;430(3):397–400. doi: 10.1016/s0014-5793(98)00704-2. [DOI] [PubMed] [Google Scholar]
  88. Hiki K., Yui Y., Hattori R., Eizawa H., Kosuga K., Kawai C. Cytosolic and membrane-bound nitric oxide synthase. Jpn J Pharmacol. 1991 Jun;56(2):217–220. doi: 10.1254/jjp.56.217. [DOI] [PubMed] [Google Scholar]
  89. Hobbs A. J., Fukuto J. M., Ignarro L. J. Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10992–10996. doi: 10.1073/pnas.91.23.10992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Hobbs A. J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol. 1999;39:191–220. doi: 10.1146/annurev.pharmtox.39.1.191. [DOI] [PubMed] [Google Scholar]
  91. Huang P. L., Dawson T. M., Bredt D. S., Snyder S. H., Fishman M. C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993 Dec 31;75(7):1273–1286. doi: 10.1016/0092-8674(93)90615-w. [DOI] [PubMed] [Google Scholar]
  92. Hurshman A. R., Krebs C., Edmondson D. E., Huynh B. H., Marletta M. A. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen. Biochemistry. 1999 Nov 30;38(48):15689–15696. doi: 10.1021/bi992026c. [DOI] [PubMed] [Google Scholar]
  93. Hurshman A. R., Marletta M. A. Nitric oxide complexes of inducible nitric oxide synthase: spectral characterization and effect on catalytic activity. Biochemistry. 1995 Apr 25;34(16):5627–5634. doi: 10.1021/bi00016a038. [DOI] [PubMed] [Google Scholar]
  94. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M. E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci. 1997 Dec 1;17(23):9157–9164. doi: 10.1523/JNEUROSCI.17-23-09157.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Jaffrey S. R., Snyder S. H. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science. 1996 Nov 1;274(5288):774–777. doi: 10.1126/science.274.5288.774. [DOI] [PubMed] [Google Scholar]
  96. Janssens S. P., Shimouchi A., Quertermous T., Bloch D. B., Bloch K. D. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992 Jul 25;267(21):14519–14522. [PubMed] [Google Scholar]
  97. Ju H., Zou R., Venema V. J., Venema R. C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem. 1997 Jul 25;272(30):18522–18525. doi: 10.1074/jbc.272.30.18522. [DOI] [PubMed] [Google Scholar]
  98. Kaufman S. The phenylalanine hydroxylating system. Adv Enzymol Relat Areas Mol Biol. 1993;67:77–264. doi: 10.1002/9780470123133.ch2. [DOI] [PubMed] [Google Scholar]
  99. Kerwin J. F., Jr, Lancaster J. R., Jr, Feldman P. L. Nitric oxide: a new paradigm for second messengers. J Med Chem. 1995 Oct 27;38(22):4343–4362. doi: 10.1021/jm00022a001. [DOI] [PubMed] [Google Scholar]
  100. King S. M., Barbarese E., Dillman J. F., 3rd, Patel-King R. S., Carson J. H., Pfister K. K. Brain cytoplasmic and flagellar outer arm dyneins share a highly conserved Mr 8,000 light chain. J Biol Chem. 1996 Aug 9;271(32):19358–19366. doi: 10.1074/jbc.271.32.19358. [DOI] [PubMed] [Google Scholar]
  101. Klatt P., Schmid M., Leopold E., Schmidt K., Werner E. R., Mayer B. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem. 1994 May 13;269(19):13861–13866. [PubMed] [Google Scholar]
  102. Klatt P., Schmidt K., Lehner D., Glatter O., Bächinger H. P., Mayer B. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J. 1995 Aug 1;14(15):3687–3695. doi: 10.1002/j.1460-2075.1995.tb00038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994 Mar 1;298(Pt 2):249–258. doi: 10.1042/bj2980249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Koarai A., Ichinose M., Sugiura H., Yamagata S., Hattori T., Shirato K. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther. 2000;13(6):267–275. doi: 10.1006/pupt.2000.0254. [DOI] [PubMed] [Google Scholar]
  105. Kobzik L., Stringer B., Balligand J. L., Reid M. B., Stamler J. S. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun. 1995 Jun 15;211(2):375–381. doi: 10.1006/bbrc.1995.1824. [DOI] [PubMed] [Google Scholar]
  106. Kolesnikov Y. A., Pan Y. X., Babey A. M., Jain S., Wilson R., Pasternak G. W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8220–8225. doi: 10.1073/pnas.94.15.8220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Komarov A. M., Wink D. A., Feelisch M., Schmidt H. H. Electron-paramagnetic resonance spectroscopy using N-methyl-D-glucamine dithiocarbamate iron cannot discriminate between nitric oxide and nitroxyl: implications for the detection of reaction products for nitric oxide synthase. Free Radic Biol Med. 2000 Mar 1;28(5):739–742. doi: 10.1016/s0891-5849(00)00156-8. [DOI] [PubMed] [Google Scholar]
  108. Komeima K., Hayashi Y., Naito Y., Watanabe Y. Inhibition of neuronal nitric-oxide synthase by calcium/ calmodulin-dependent protein kinase IIalpha through Ser847 phosphorylation in NG108-15 neuronal cells. J Biol Chem. 2000 Sep 8;275(36):28139–28143. doi: 10.1074/jbc.M003198200. [DOI] [PubMed] [Google Scholar]
  109. Koppenol W. H., Moreno J. J., Pryor W. A., Ischiropoulos H., Beckman J. S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 1992 Nov-Dec;5(6):834–842. doi: 10.1021/tx00030a017. [DOI] [PubMed] [Google Scholar]
  110. Korth H. G., Sustmann R., Thater C., Butler A. R., Ingold K. U. On the mechanism of the nitric oxide synthase-catalyzed conversion of N omega-hydroxyl-L-arginine to citrulline and nitric oxide. J Biol Chem. 1994 Jul 8;269(27):17776–17779. [PubMed] [Google Scholar]
  111. Kröncke K. D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol. 1998 Aug;113(2):147–156. doi: 10.1046/j.1365-2249.1998.00648.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Lainé R., de Montellano P. R. Neuronal nitric oxide synthase isoforms alpha and mu are closely related calpain-sensitive proteins. Mol Pharmacol. 1998 Aug;54(2):305–312. doi: 10.1124/mol.54.2.305. [DOI] [PubMed] [Google Scholar]
  113. Laszlo F., Whittle B. J., Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol. 1994 Apr;111(4):1309–1315. doi: 10.1111/j.1476-5381.1994.tb14887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Lee C. M., Robinson L. J., Michel T. Oligomerization of endothelial nitric oxide synthase. Evidence for a dominant negative effect of truncation mutants. J Biol Chem. 1995 Nov 17;270(46):27403–27406. doi: 10.1074/jbc.270.46.27403. [DOI] [PubMed] [Google Scholar]
  115. Li H., Raman C. S., Glaser C. B., Blasko E., Young T. A., Parkinson J. F., Whitlow M., Poulos T. L. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. J Biol Chem. 1999 Jul 23;274(30):21276–21284. doi: 10.1074/jbc.274.30.21276. [DOI] [PubMed] [Google Scholar]
  116. List B. M., Klösch B., Völker C., Gorren A. C., Sessa W. C., Werner E. R., Kukovetz W. R., Schmidt K., Mayer B. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J. 1997 Apr 1;323(Pt 1):159–165. doi: 10.1042/bj3230159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Liu J., García-Cardeña G., Sessa W. C. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry. 1995 Sep 26;34(38):12333–12340. doi: 10.1021/bi00038a029. [DOI] [PubMed] [Google Scholar]
  118. Liu J., Hughes T. E., Sessa W. C. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol. 1997 Jun 30;137(7):1525–1535. doi: 10.1083/jcb.137.7.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Lowe P. N., Smith D., Stammers D. K., Riveros-Moreno V., Moncada S., Charles I., Boyhan A. Identification of the domains of neuronal nitric oxide synthase by limited proteolysis. Biochem J. 1996 Feb 15;314(Pt 1):55–62. doi: 10.1042/bj3140055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Lundberg J. O., Farkas-Szallasi T., Weitzberg E., Rinder J., Lidholm J., Anggåard A., Hökfelt T., Lundberg J. M., Alving K. High nitric oxide production in human paranasal sinuses. Nat Med. 1995 Apr;1(4):370–373. doi: 10.1038/nm0495-370. [DOI] [PubMed] [Google Scholar]
  121. László F., Whittle B. J. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon. Eur J Pharmacol. 1997 Sep 3;334(1):99–102. doi: 10.1016/s0014-2999(97)01163-1. [DOI] [PubMed] [Google Scholar]
  122. Ma X. L., Gao F., Liu G. L., Lopez B. L., Christopher T. A., Fukuto J. M., Wink D. A., Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14617–14622. doi: 10.1073/pnas.96.25.14617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Magee T., Fuentes A. M., Garban H., Rajavashisth T., Marquez D., Rodriguez J. A., Rajfer J., Gonzalez-Cadavid N. F. Cloning of a novel neuronal nitric oxide synthase expressed in penis and lower urinary tract. Biochem Biophys Res Commun. 1996 Sep 4;226(1):145–151. doi: 10.1006/bbrc.1996.1324. [DOI] [PubMed] [Google Scholar]
  124. Marletta M. A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 1994 Sep 23;78(6):927–930. doi: 10.1016/0092-8674(94)90268-2. [DOI] [PubMed] [Google Scholar]
  125. Marsden P. A., Schappert K. T., Chen H. S., Flowers M., Sundell C. L., Wilcox J. N., Lamas S., Michel T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992 Aug 3;307(3):287–293. doi: 10.1016/0014-5793(92)80697-f. [DOI] [PubMed] [Google Scholar]
  126. Matsuda H., Iyanagi T. Calmodulin activates intramolecular electron transfer between the two flavins of neuronal nitric oxide synthase flavin domain. Biochim Biophys Acta. 1999 Dec 27;1473(2-3):345–355. doi: 10.1016/s0304-4165(99)00193-2. [DOI] [PubMed] [Google Scholar]
  127. Mayer B., Wu C., Gorren A. C., Pfeiffer S., Schmidt K., Clark P., Stuehr D. J., Werner E. R. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin. Biochemistry. 1997 Jul 8;36(27):8422–8427. doi: 10.1021/bi970144z. [DOI] [PubMed] [Google Scholar]
  128. McCabe T. J., Fulton D., Roman L. J., Sessa W. C. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem. 2000 Mar 3;275(9):6123–6128. doi: 10.1074/jbc.275.9.6123. [DOI] [PubMed] [Google Scholar]
  129. McCall T. B., Feelisch M., Palmer R. M., Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol. 1991 Jan;102(1):234–238. doi: 10.1111/j.1476-5381.1991.tb12159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. McMillan K., Adler M., Auld D. S., Baldwin J. J., Blasko E., Browne L. J., Chelsky D., Davey D., Dolle R. E., Eagen K. A. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1506–1511. doi: 10.1073/pnas.97.4.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. McMillan K., Masters B. S. Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction. Biochemistry. 1993 Sep 28;32(38):9875–9880. doi: 10.1021/bi00089a001. [DOI] [PubMed] [Google Scholar]
  132. McMillan K., Masters B. S. Prokaryotic expression of the heme- and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: identification of the heme-binding proximal thiolate ligand as cysteine-415. Biochemistry. 1995 Mar 21;34(11):3686–3693. doi: 10.1021/bi00011a025. [DOI] [PubMed] [Google Scholar]
  133. Melchiorri C., Meliconi R., Frizziero L., Silvestri T., Pulsatelli L., Mazzetti I., Borzì R. M., Uguccioni M., Facchini A. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 1998 Dec;41(12):2165–2174. doi: 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  134. Michel J. B., Feron O., Sacks D., Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem. 1997 Jun 20;272(25):15583–15586. doi: 10.1074/jbc.272.25.15583. [DOI] [PubMed] [Google Scholar]
  135. Michel T. Targeting and translocation of endothelial nitric oxide synthase. Braz J Med Biol Res. 1999 Nov;32(11):1361–1366. doi: 10.1590/s0100-879x1999001100006. [DOI] [PubMed] [Google Scholar]
  136. Millar T. M., Stevens C. R., Benjamin N., Eisenthal R., Harrison R., Blake D. R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 1998 May 8;427(2):225–228. doi: 10.1016/s0014-5793(98)00430-x. [DOI] [PubMed] [Google Scholar]
  137. Miller R. T., Martásek P., Roman L. J., Nishimura J. S., Masters B. S. Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production. Biochemistry. 1997 Dec 9;36(49):15277–15284. doi: 10.1021/bi972022c. [DOI] [PubMed] [Google Scholar]
  138. Misko T. P., Moore W. M., Kasten T. P., Nickols G. A., Corbett J. A., Tilton R. G., McDaniel M. L., Williamson J. R., Currie M. G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 1993 Mar 16;233(1):119–125. doi: 10.1016/0014-2999(93)90357-n. [DOI] [PubMed] [Google Scholar]
  139. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  140. Moore W. M., Webber R. K., Jerome G. M., Tjoeng F. S., Misko T. P., Currie M. G. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem. 1994 Nov 11;37(23):3886–3888. doi: 10.1021/jm00049a007. [DOI] [PubMed] [Google Scholar]
  141. Murphy M. E., Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10860–10864. doi: 10.1073/pnas.88.23.10860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Muscará M. N., Wallace J. L. Nitric Oxide. V. therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol. 1999 Jun;276(6 Pt 1):G1313–G1316. doi: 10.1152/ajpgi.1999.276.6.G1313. [DOI] [PubMed] [Google Scholar]
  143. Nagayama M., Zhang F., Iadecola C. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J Cereb Blood Flow Metab. 1998 Oct;18(10):1107–1113. doi: 10.1097/00004647-199810000-00007. [DOI] [PubMed] [Google Scholar]
  144. Nakane M., Mitchell J., Förstermann U., Murad F. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1396–1402. doi: 10.1016/s0006-291x(05)81351-8. [DOI] [PubMed] [Google Scholar]
  145. Nakane M., Schmidt H. H., Pollock J. S., Förstermann U., Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 1993 Jan 25;316(2):175–180. doi: 10.1016/0014-5793(93)81210-q. [DOI] [PubMed] [Google Scholar]
  146. Narayanan K., Spack L., McMillan K., Kilbourn R. G., Hayward M. A., Masters B. S., Griffith O. W. S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo. J Biol Chem. 1995 May 12;270(19):11103–11110. doi: 10.1074/jbc.270.19.11103. [DOI] [PubMed] [Google Scholar]
  147. Nathan C., Xie Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994 Sep 23;78(6):915–918. doi: 10.1016/0092-8674(94)90266-6. [DOI] [PubMed] [Google Scholar]
  148. Nilsson B. O., Kockum I., Rosengren E. Inhibition of diamine oxidase promotes uptake of putrescine from rat small intestine. Inflamm Res. 1996 Oct;45(10):513–518. doi: 10.1007/BF02311088. [DOI] [PubMed] [Google Scholar]
  149. Nishida C. R., Ortiz de Montellano P. R. Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element. J Biol Chem. 1999 May 21;274(21):14692–14698. doi: 10.1074/jbc.274.21.14692. [DOI] [PubMed] [Google Scholar]
  150. Noble M. A., Munro A. W., Rivers S. L., Robledo L., Daff S. N., Yellowlees L. J., Shimizu T., Sagami I., Guillemette J. G., Chapman S. K. Potentiometric analysis of the flavin cofactors of neuronal nitric oxide synthase. Biochemistry. 1999 Dec 14;38(50):16413–16418. doi: 10.1021/bi992150w. [DOI] [PubMed] [Google Scholar]
  151. O'Neill M. J., Murray T. K., McCarty D. R., Hicks C. A., Dell C. P., Patrick K. E., Ward M. A., Osborne D. J., Wiernicki T. R., Roman C. R. ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia. Brain Res. 2000 Jul 21;871(2):234–244. doi: 10.1016/s0006-8993(00)02471-9. [DOI] [PubMed] [Google Scholar]
  152. Ogura T., Yokoyama T., Fujisawa H., Kurashima Y., Esumi H. Structural diversity of neuronal nitric oxide synthase mRNA in the nervous system. Biochem Biophys Res Commun. 1993 Jun 30;193(3):1014–1022. doi: 10.1006/bbrc.1993.1726. [DOI] [PubMed] [Google Scholar]
  153. Ou P., Wolff S. P. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol. 1993 Oct 5;46(7):1139–1144. doi: 10.1016/0006-2952(93)90461-5. [DOI] [PubMed] [Google Scholar]
  154. Parmentier S., Böhme G. A., Lerouet D., Damour D., Stutzmann J. M., Margaill I., Plotkine M. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br J Pharmacol. 1999 May;127(2):546–552. doi: 10.1038/sj.bjp.0702549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Pfeiffer S., Gorren A. C., Pitters E., Schmidt K., Werner E. R., Mayer B. Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin. Biochem J. 1997 Dec 1;328(Pt 2):349–352. doi: 10.1042/bj3280349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Polte T., Abate A., Dennery P. A., Schröder H. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1209–1215. doi: 10.1161/01.atv.20.5.1209. [DOI] [PubMed] [Google Scholar]
  157. Pou S., Pou W. S., Bredt D. S., Snyder S. H., Rosen G. M. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992 Dec 5;267(34):24173–24176. [PubMed] [Google Scholar]
  158. Poulos T. L., Li H., Raman C. S. Heme-mediated oxygen activation in biology: cytochrome c oxidase and nitric oxide synthase. Curr Opin Chem Biol. 1999 Apr;3(2):131–137. doi: 10.1016/s1367-5931(99)80024-6. [DOI] [PubMed] [Google Scholar]
  159. Prabhakar P., Thatte H. S., Goetz R. M., Cho M. R., Golan D. E., Michel T. Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem. 1998 Oct 16;273(42):27383–27388. doi: 10.1074/jbc.273.42.27383. [DOI] [PubMed] [Google Scholar]
  160. Presta A., Siddhanta U., Wu C., Sennequier N., Huang L., Abu-Soud H. M., Erzurum S., Stuehr D. J. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry. 1998 Jan 6;37(1):298–310. doi: 10.1021/bi971944c. [DOI] [PubMed] [Google Scholar]
  161. Presta A., Siddhanta U., Wu C., Sennequier N., Huang L., Abu-Soud H. M., Erzurum S., Stuehr D. J. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry. 1998 Jan 6;37(1):298–310. doi: 10.1021/bi971944c. [DOI] [PubMed] [Google Scholar]
  162. Pufahl R. A., Wishnok J. S., Marletta M. A. Hydrogen peroxide-supported oxidation of NG-hydroxy-L-arginine by nitric oxide synthase. Biochemistry. 1995 Feb 14;34(6):1930–1941. doi: 10.1021/bi00006a014. [DOI] [PubMed] [Google Scholar]
  163. Raman C. S., Li H., Martásek P., Král V., Masters B. S., Poulos T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 1998 Dec 23;95(7):939–950. doi: 10.1016/s0092-8674(00)81718-3. [DOI] [PubMed] [Google Scholar]
  164. Ratovitski E. A., Alam M. R., Quick R. A., McMillan A., Bao C., Kozlovsky C., Hand T. A., Johnson R. C., Mains R. E., Eipper B. A. Kalirin inhibition of inducible nitric-oxide synthase. J Biol Chem. 1999 Jan 8;274(2):993–999. doi: 10.1074/jbc.274.2.993. [DOI] [PubMed] [Google Scholar]
  165. Rees D. D., Monkhouse J. E., Cambridge D., Moncada S. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol. 1998 Jun;124(3):540–546. doi: 10.1038/sj.bjp.0701815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Rees D. D., Palmer R. M., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990 Nov;101(3):746–752. doi: 10.1111/j.1476-5381.1990.tb14151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Reif A., Fröhlich L. G., Kotsonis P., Frey A., Bömmel H. M., Wink D. A., Pfleiderer W., Schmidt H. H. Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem. 1999 Aug 27;274(35):24921–24929. doi: 10.1074/jbc.274.35.24921. [DOI] [PubMed] [Google Scholar]
  168. Richards M. K., Marletta M. A. Characterization of neuronal nitric oxide synthase and a C415H mutant, purified from a baculovirus overexpression system. Biochemistry. 1994 Dec 13;33(49):14723–14732. doi: 10.1021/bi00253a010. [DOI] [PubMed] [Google Scholar]
  169. Rodríguez-Crespo I., Straub W., Gavilanes F., Ortiz de Montellano P. R. Binding of dynein light chain (PIN) to neuronal nitric oxide synthase in the absence of inhibition. Arch Biochem Biophys. 1998 Nov 15;359(2):297–304. doi: 10.1006/abbi.1998.0928. [DOI] [PubMed] [Google Scholar]
  170. Rusche K. M., Spiering M. M., Marletta M. A. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry. 1998 Nov 3;37(44):15503–15512. doi: 10.1021/bi9813936. [DOI] [PubMed] [Google Scholar]
  171. Salerno J. C., Harris D. E., Irizarry K., Patel B., Morales A. J., Smith S. M., Martasek P., Roman L. J., Masters B. S., Jones C. L. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem. 1997 Nov 21;272(47):29769–29777. doi: 10.1074/jbc.272.47.29769. [DOI] [PubMed] [Google Scholar]
  172. Santolini J., Adak S., Curran C. M., Stuehr D. J. A kinetic simulation model that describes catalysis and regulation in nitric-oxide synthase. J Biol Chem. 2001 Jan 12;276(2):1233–1243. doi: 10.1074/jbc.M006858200. [DOI] [PubMed] [Google Scholar]
  173. Schepens J., Cuppen E., Wieringa B., Hendriks W. The neuronal nitric oxide synthase PDZ motif binds to -G(D,E)XV* carboxyterminal sequences. FEBS Lett. 1997 Jun 2;409(1):53–56. doi: 10.1016/s0014-5793(97)00481-x. [DOI] [PubMed] [Google Scholar]
  174. Schmidt H. H., Hofmann H., Schindler U., Shutenko Z. S., Cunningham D. D., Feelisch M. No .NO from NO synthase. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14492–14497. doi: 10.1073/pnas.93.25.14492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Schmidt H. H., Murad F. Purification and characterization of a human NO synthase. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1372–1377. doi: 10.1016/0006-291x(91)92090-7. [DOI] [PubMed] [Google Scholar]
  176. Seiler N., Bolkenius F. N., Knödgen B. The influence of catabolic reactions on polyamine excretion. Biochem J. 1985 Jan 1;225(1):219–226. doi: 10.1042/bj2250219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Sennequier N., Wolan D., Stuehr D. J. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer. J Biol Chem. 1999 Jan 8;274(2):930–938. doi: 10.1074/jbc.274.2.930. [DOI] [PubMed] [Google Scholar]
  178. Sharpe M. A., Cooper C. E. Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite. Biochem J. 1998 May 15;332(Pt 1):9–19. doi: 10.1042/bj3320009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Shaul P. W., Smart E. J., Robinson L. J., German Z., Yuhanna I. S., Ying Y., Anderson R. G., Michel T. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996 Mar 15;271(11):6518–6522. doi: 10.1074/jbc.271.11.6518. [DOI] [PubMed] [Google Scholar]
  180. Sherman P. A., Laubach V. E., Reep B. R., Wood E. R. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry. 1993 Nov 2;32(43):11600–11605. doi: 10.1021/bi00094a017. [DOI] [PubMed] [Google Scholar]
  181. Sheta E. A., McMillan K., Masters B. S. Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase. J Biol Chem. 1994 May 27;269(21):15147–15153. [PubMed] [Google Scholar]
  182. Shirato M., Sakamoto T., Uchida Y., Nomura A., Ishii Y., Iijima H., Goto Y., Hasegawa S. Molecular cloning and characterization of Ca2+-dependent inducible nitric oxide synthase from guinea-pig lung. Biochem J. 1998 Aug 1;333(Pt 3):795–799. doi: 10.1042/bj3330795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Siddhanta U., Wu C., Abu-Soud H. M., Zhang J., Ghosh D. K., Stuehr D. J. Heme iron reduction and catalysis by a nitric oxide synthase heterodimer containing one reductase and two oxygenase domains. J Biol Chem. 1996 Mar 29;271(13):7309–7312. doi: 10.1074/jbc.271.13.7309. [DOI] [PubMed] [Google Scholar]
  184. Silvagno F., Xia H., Bredt D. S. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem. 1996 May 10;271(19):11204–11208. doi: 10.1074/jbc.271.19.11204. [DOI] [PubMed] [Google Scholar]
  185. Sono Masanori, Roach Mark P., Coulter Eric D., Dawson John H. Heme-Containing Oxygenases. Chem Rev. 1996 Nov 7;96(7):2841–2888. doi: 10.1021/cr9500500. [DOI] [PubMed] [Google Scholar]
  186. Stamler J. S., Loh E., Roddy M. A., Currie K. E., Creager M. A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994 May;89(5):2035–2040. doi: 10.1161/01.cir.89.5.2035. [DOI] [PubMed] [Google Scholar]
  187. Stricker N. L., Christopherson K. S., Yi B. A., Schatz P. J., Raab R. W., Dawes G., Bassett D. E., Jr, Bredt D. S., Li M. PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences. Nat Biotechnol. 1997 Apr;15(4):336–342. doi: 10.1038/nbt0497-336. [DOI] [PubMed] [Google Scholar]
  188. Stroes E., Hijmering M., van Zandvoort M., Wever R., Rabelink T. J., van Faassen E. E. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett. 1998 Nov 6;438(3):161–164. doi: 10.1016/s0014-5793(98)01292-7. [DOI] [PubMed] [Google Scholar]
  189. Stuehr D. J., Cho H. J., Kwon N. S., Weise M. F., Nathan C. F. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7773–7777. doi: 10.1073/pnas.88.17.7773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Stuehr D. J., Kwon N. S., Nathan C. F., Griffith O. W., Feldman P. L., Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem. 1991 Apr 5;266(10):6259–6263. [PubMed] [Google Scholar]
  191. Stuehr D. J. Mammalian nitric oxide synthases. Biochim Biophys Acta. 1999 May 5;1411(2-3):217–230. doi: 10.1016/s0005-2728(99)00016-x. [DOI] [PubMed] [Google Scholar]
  192. Tatoyan A., Giulivi C. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria. J Biol Chem. 1998 May 1;273(18):11044–11048. doi: 10.1074/jbc.273.18.11044. [DOI] [PubMed] [Google Scholar]
  193. Thomsen L. L., Scott J. M., Topley P., Knowles R. G., Keerie A. J., Frend A. J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 1997 Aug 1;57(15):3300–3304. [PubMed] [Google Scholar]
  194. Venema R. C., Ju H., Zou R., Ryan J. W., Venema V. J. Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem. 1997 Jan 10;272(2):1276–1282. doi: 10.1074/jbc.272.2.1276. [DOI] [PubMed] [Google Scholar]
  195. Venema V. J., Ju H., Zou R., Venema R. C. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem. 1997 Nov 7;272(45):28187–28190. doi: 10.1074/jbc.272.45.28187. [DOI] [PubMed] [Google Scholar]
  196. Venema V. J., Marrero M. B., Venema R. C. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun. 1996 Sep 24;226(3):703–710. doi: 10.1006/bbrc.1996.1417. [DOI] [PubMed] [Google Scholar]
  197. Vásquez-Vivar J., Hogg N., Martásek P., Karoui H., Pritchard K. A., Jr, Kalyanaraman B. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem. 1999 Sep 17;274(38):26736–26742. doi: 10.1074/jbc.274.38.26736. [DOI] [PubMed] [Google Scholar]
  198. Vásquez-Vivar J., Kalyanaraman B., Martásek P., Hogg N., Masters B. S., Karoui H., Tordo P., Pritchard K. A., Jr Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9220–9225. doi: 10.1073/pnas.95.16.9220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Wang J., Stuehr D. J., Ikeda-Saito M., Rousseau D. L. Heme coordination and structure of the catalytic site in nitric oxide synthase. J Biol Chem. 1993 Oct 25;268(30):22255–22258. [PubMed] [Google Scholar]
  200. Wang J., Stuehr D. J., Rousseau D. L. Tetrahydrobiopterin-deficient nitric oxide synthase has a modified heme environment and forms a cytochrome P-420 analogue. Biochemistry. 1995 May 30;34(21):7080–7087. doi: 10.1021/bi00021a020. [DOI] [PubMed] [Google Scholar]
  201. Wang Y., Goligorsky M. S., Lin M., Wilcox J. N., Marsden P. A. A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase. J Biol Chem. 1997 Apr 25;272(17):11392–11401. [PubMed] [Google Scholar]
  202. Wang Y., Newton D. C., Robb G. B., Kau C. L., Miller T. L., Cheung A. H., Hall A. V., VanDamme S., Wilcox J. N., Marsden P. A. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12150–12155. doi: 10.1073/pnas.96.21.12150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Watmough N. J., Butland G., Cheesman M. R., Moir J. W., Richardson D. J., Spiro S. Nitric oxide in bacteria: synthesis and consumption. Biochim Biophys Acta. 1999 May 5;1411(2-3):456–474. doi: 10.1016/s0005-2728(99)00032-8. [DOI] [PubMed] [Google Scholar]
  204. Weiner C. P., Lizasoain I., Baylis S. A., Knowles R. G., Charles I. G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5212–5216. doi: 10.1073/pnas.91.11.5212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Werner E. R., Pitters E., Schmidt K., Wachter H., Werner-Felmayer G., Mayer B. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J. 1996 Nov 15;320(Pt 1):193–196. doi: 10.1042/bj3200193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Wink D. A., Feelisch M., Fukuto J., Chistodoulou D., Jourd'heuil D., Grisham M. B., Vodovotz Y., Cook J. A., Krishna M., DeGraff W. G. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys. 1998 Mar 1;351(1):66–74. doi: 10.1006/abbi.1997.0565. [DOI] [PubMed] [Google Scholar]
  207. Witteveen C. F., Giovanelli J., Kaufman S. Reactivity of tetrahydrobiopterin bound to nitric-oxide synthase. J Biol Chem. 1999 Oct 15;274(42):29755–29762. doi: 10.1074/jbc.274.42.29755. [DOI] [PubMed] [Google Scholar]
  208. Wolff D. J., Datto G. A., Samatovicz R. A., Tempsick R. A. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem. 1993 May 5;268(13):9425–9429. [PubMed] [Google Scholar]
  209. Wolff D. J., Lubeskie A. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys. 1995 Jan 10;316(1):290–301. doi: 10.1006/abbi.1995.1040. [DOI] [PubMed] [Google Scholar]
  210. Wolff D. J., Lubeskie A., Gauld D. S., Neulander M. J. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine. Eur J Pharmacol. 1998 Jun 5;350(2-3):325–334. doi: 10.1016/s0014-2999(98)00267-2. [DOI] [PubMed] [Google Scholar]
  211. Wray G. M., Millar C. G., Hinds C. J., Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock. 1998 May;9(5):329–335. doi: 10.1097/00024382-199805000-00003. [DOI] [PubMed] [Google Scholar]
  212. Xia Y., Roman L. J., Masters B. S., Zweier J. L. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem. 1998 Aug 28;273(35):22635–22639. doi: 10.1074/jbc.273.35.22635. [DOI] [PubMed] [Google Scholar]
  213. Xia Y., Zweier J. L. Direct measurement of nitric oxide generation from nitric oxide synthase. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12705–12710. doi: 10.1073/pnas.94.23.12705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Yildiz G., Demiryürek A. T., Sahin-Erdemli I., Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol. 1998 Jul;124(5):905–910. doi: 10.1038/sj.bjp.0701924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Young R. J., Beams R. M., Carter K., Clark H. A., Coe D. M., Chambers C. L., Davies P. I., Dawson J., Drysdale M. J., Franzman K. W. Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine. Bioorg Med Chem Lett. 2000 Mar 20;10(6):597–600. doi: 10.1016/s0960-894x(00)00055-x. [DOI] [PubMed] [Google Scholar]
  216. Zhang Z. G., Reif D., Macdonald J., Tang W. X., Kamp D. K., Gentile R. J., Shakespeare W. C., Murray R. J., Chopp M. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1996 Jul;16(4):599–604. doi: 10.1097/00004647-199607000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES